contract research Organization india(CRO india)
Services
 
Contract Resrearch
Pharmaceutical Pharmaceutical manufacturers
Biotech Services
Genomics Services
Proteomics Services
Bioinformatics
Biostatistics
LIMS
Combinatorial Chemistry
DNA Microarray Services
Patents Department
Agri BioTechnology
NanoTechnology
SSD
Strategic alliances
Career
Contact Us
contract research services
 
pharma cro
Pharmaceutical Contract Manufacturing Organization(CMO) contract research labs contract Pharmaceutical manufacturing biotechnology contract research bioinformatics services biotechnology services
cro contract research in india
Advantage NanoBioServices

NanoBioServices is a contract research Organization with broad expertise in the planning, execution and interpretation of research projects. Our scientists have worked in Best labs giving us a focused, comprehensive planning which leads to easy solutions of complex problems. 
Our collaboration with leaders in the business help organizations resolve some of their most complex scientific problems with solutions that deliver results to their satisfation.

The biopharmaceutical industry in India has all the capabilities to become a dominant player. The consumption of biotech products in India is expected to quadruple in the next decade. The human and animal segment of the industry alone is growing by at least 20%. NanoBioServices has a rich human capital, which is the strongest asset for this knowledge-based industry. India has a large English speaking base and, according to Confederation of Indian Industry estimates, produces roughly 2.5 million graduates in IT, engineering and life sciences, about 650,000 postgraduates and nearly 1500 PhDs qualified in biosciences and engineering each year. India has become a very attractive base as the cost of infrastructure is relatively lower compared to other nations.

The pharma industry today has arrived at a very exiting point where biotechnology and genetic engineering opening up new avenues to produce better,specific and targeted drugs.

Global spending on R&D is likely to grow(According to one estimate it can be anything from 8 to 12 per cent by 2010) and trends indicate that global research expenditure (30% of it)will be outside established corporate boundaries iether on a contract or on thebasis of part time investment.

Hence Nanobioservices intends to serve the Biotechnology and Pharmaceutical industry in research-based activities like informatics, structure-based design and synthesis, Genomics, Proteomics and molecular biology.

 

List ... Services offered

 
CRO
contract research organizations(CRO)